Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.
2.
3.

Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.

Ignaut DA, Schwartz SL, Sarwat S, Murphy HL.

Diabetes Educ. 2009 Sep-Oct;35(5):789-98. doi: 10.1177/0145721709340056.

PMID:
19783767
4.

Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.

Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK.

Diabetes Technol Ther. 2014 Feb;16(2):76-83. doi: 10.1089/dia.2013.0172. Epub 2013 Nov 23.

PMID:
24266497
5.

Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.

Brunton S.

Diabetes Technol Ther. 2008 Aug;10(4):247-56. doi: 10.1089/dia.2008.0287. Review.

PMID:
18715198
6.

Considerations for diabetes: treatment with insulin pen devices.

Cuddihy RM, Borgman SK.

Am J Ther. 2013 Nov-Dec;20(6):694-702. doi: 10.1097/MJT.0b013e318217a5e3. Review.

PMID:
21768872
7.

Insulin pens: the modern delivery devices.

Baruah MP.

J Assoc Physicians India. 2011 Apr;59 Suppl:38-40.

PMID:
21823254
8.

Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.

Schwartz SL, Ignaut DA, Bodie JN.

Expert Rev Med Devices. 2010 Nov;7(6):735-43. doi: 10.1586/erd.10.63.

PMID:
21050084
9.

Overview of insulin delivery pen devices.

Kroon L.

J Am Pharm Assoc (2003). 2009 Sep-Oct;49(5):e118-31. doi: 10.1331/JAPhA.2009.08125. Review.

PMID:
19692314
10.
11.

FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.

Bailey T, Campos C.

Expert Rev Med Devices. 2012 May;9(3):209-17. doi: 10.1586/erd.12.13. Epub 2012 Apr 3. Review.

PMID:
22471783
12.

Insulin delivery by injection in children and adolescents with diabetes.

Hanas R, de Beaufort C, Hoey H, Anderson B.

Pediatr Diabetes. 2011 Aug;12(5):518-26. doi: 10.1111/j.1399-5448.2010.00731.x. Epub 2011 Apr 11. Review.

PMID:
21481121
13.

Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.

Pfützner A, Asakura T, Sommavilla B, Lee W.

Expert Opin Drug Deliv. 2008 Aug;5(8):915-25. doi: 10.1517/17425247.5.8.915 . Review.

PMID:
18713000
16.

Preference for a new prefilled insulin pen compared with the original pen.

Garg S, Bailey T, DeLuzio T, Pollom D.

Curr Med Res Opin. 2011 Dec;27(12):2323-33. doi: 10.1185/03007995.2011.630721. Epub 2011 Oct 31.

PMID:
21988614
17.

Incidence, prevalence, and trend analysis of the use of insulin delivery systems in the United States (2005 to 2011).

Perez-Nieves M, Jiang D, Eby E.

Curr Med Res Opin. 2015 May;31(5):891-9. doi: 10.1185/03007995.2015.1020366. Epub 2015 Apr 7.

PMID:
25710707
18.

The importance of patient compliance with insulin pens: how can a new user-friendly pen help?

Pafili K, Papanas N.

Expert Opin Drug Deliv. 2014 May;11(5):629-32. doi: 10.1517/17425247.2014.894505. Epub 2014 Mar 24.

PMID:
24661150
19.

A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.

Hyllested-Winge J, Jensen KH, Rex J.

Clin Drug Investig. 2010;30(10):643-74. doi: 10.2165/11584360-000000000-00000. Review.

PMID:
20701399
20.

Supplemental Content

Support Center